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Abstract:  
 In the United States, well-documented and persistent health disparities exist between 
racial and ethnic populations, including inequities in health care access, quality, and outcomes 
for life-threatening diseases. Although there is evidence of decreased hospice use among racial 
and ethnic minorities, there is minimal research on disparities in non-hospice-based palliative 
care, including inpatient specialty palliative care. By optimizing symptom management and 
supporting patient and family-centered decision-making, specialty palliative care may have the 
potential to reduce disparities in end-of-life care quality and outcomes. 
 This paper aims to fill the gap in literature on racial and ethnic disparities in the inpatient 
specialty palliative care consultation setting. The first section presents a systematic review of 
the literature on associations between race/ethnicity and care processes and outcomes among 
patients who receive an inpatient palliative care consultation. The review suggests that most 
patients move toward less aggressive care after inpatient palliative care consultation, regardless 
of race or ethnicity. Inpatient palliative care consultation may be a means to increase minority 
patients’ access to hospice services. 
 The second section presents an observational study comparing patient characteristics, 
adherence to palliative care quality measures, and clinical outcomes in encounters for seriously 
ill black patients versus white patients seen on an inpatient specialty palliative care consultation 
service. Compared to white patient encounters, quality measure adherence was similar in 
encounters for black patients, although black patients were more likely to have their 
spiritual/religious concerns addressed. Advance direction completion occurred at similar rates in 
black and white patient encounters, suggesting that specialty palliative care consultation may 
offer an opportunity to reduce the racial disparity in advance care planning. 
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Does Patient Race and Ethnicity affect Inpatient Specialty Palliative Care Processes and 
Outcomes? A Systematic Review of the Literature  
INTRODUCTION 
 Racial and ethnic disparities in health care access, quality, and outcomes are well-documented 
across a wide range of medical conditions, including life-threatening illnesses such as cancer, heart 
failure, end-stage liver disease, and end-stage renal disease.
1
 Examples include racial inequities in pain 
management,
2,3
 disparities in family satisfaction with the quality of end-of-life care and 
communication,
4,5
 and differential treatment patterns and quality-of-life outcomes in breast cancer 
patients.
6
 Black and Hispanic/Latino patients are also more likely to receive aggressive care at the end of 
life and are less likely to complete advance directives.
7
 Although patient and family preferences likely 
contribute to this trend, the etiology is multi-faceted and not well-understood.
4
  
 Additionally, compared to whites, racial/ethnic minorities use hospice at disproportionately 
lower rates.
8
 In particular, black patients have comparatively low rates of hospice enrollment, even after 
controlling for income level, access to care, education, diagnosis of heart failure, and other covariates.
9-12
 
Research on disparities in patient-reported outcomes of hospice has been inconsistent. One study found 
higher pain levels and decreased family-reported satisfaction with end-of life care among black hospice 
patients compared to non-Hispanic white patients.
13
 Conversely, another study found no difference in 
satisfaction with hospice services and outcomes between black and white patients and families in a large 
hospice organization.
14
  
 In contrast to the evidence of health disparities in advance directive completion and hospice use, 
research on disparities in palliative care quality and outcomes is limited and primarily restricted to the 
hospice setting. Specialty palliative care is patient and family-centered care, usually delivered by an 
interdisciplinary team, to optimize quality of life during serious illness by anticipating, preventing or 
treating suffering.  Interventions address physical, emotional, social and spiritual needs, and support for 
autonomy and healthcare decision-making.  Palliative care differs from hospice because it is available 
regardless of stage of disease or life expectancy.
15
 In the United States, specialty palliative care is 
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available as a consultative service in most acute care hospitals. Inpatient palliative care consultation 
(IPCC) offers a key opportunity to improve symptom management, facilitate discussions about treatment 
preferences and decision-making, and connect patients and families with outpatient services such as 
hospice and caregiver support services. By offering these benefits in a systematic manner and 
establishing contact with patients who face multiple barriers to accessing palliative care in the outpatient 
setting, IPCC could be a way to decrease racial disparities in outcomes among patients with serious and 
life-threatening illnesses. On the other hand, disparities could persist or even worsen if there is 
inequitable application of quality practices, differential access to IPCC, or racial/ethnic differences in 
patient responses to specialty palliative care interventions. 
 As palliative care moves toward a focus on quality and outcomes measurement, it is important to 
determine whether racial disparities exist in the specialty palliative care consultation setting. We 
conducted a systematic review of the literature to determine whether race or ethnicity is associated with 
different care processes or outcomes among patients who receive specialty palliative care consultation in 
the acute care hospital setting.  
 
METHODS 
Search Strategy 
 We searched MEDLINE (using PubMed), CINAHL (using EBSCO), and EMBASE from 
January 1, 1990 through March 1, 2017 for English-language articles in peer-reviewed publications. 
With the assistance of a health sciences librarian, we developed our search strategy by performing 
multiple trial searches with different combinations of medical subheading terms and keywords related to 
palliative care and health care disparities until we reached the most parsimonious query that yielded 
primarily relevant articles. Our final strategy searched for the medical subheading terms “healthcare 
disparities” and “palliative medicine” and for the following terms in all search fields: palliative care, 
inpatient palliative care, specialty palliative care, palliative care consultation, palliative care consult, 
disparities, race, ethnicity, and African Americans (Appendix 1). 
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Study Selection 
 Studies were included if they met the following criteria: 1) experimental, quasi-experimental, or 
observational design; 2) study population defined by receipt of inpatient specialty palliative care 
consultation in the acute care hospital setting; and 3) study aim was to examine racial or ethnic 
differences in care processes and/or outcomes among patients who received a palliative care 
consultation.  We limited our review to studies conducted in the United States and Canada to minimize 
the complicating effects of vastly different racial/ethnic categorizations, socioeconomic and political 
inequities, and histories of racism across different geographic regions. We also excluded reviews and 
case reports, as well as studies that aimed to determine whether rates of IPCC differed across racial and 
ethnic groups in the general hospitalized population. One reviewer (J.L) evaluated all records for 
eligibility based on abstract and title and, if necessary, based on the full text of the article (Figure 1). 
Data Extraction and Quality Assessment 
 One author (J.L) extracted standardized information from each study, including study design, 
setting, aims, population, exposure variables (i.e. race or ethnicity, as defined by the study authors), 
outcomes, major findings, and methodological strengths and weaknesses. The categories black and 
African American, white and Caucasian, and Hispanic and Latino were considered synonyms, 
respectively, for the purpose of narrative synthesis. To assess the risk of bias in each study, we used an 
adapted version of the Cochrane Collaboration’s tool.16 The Cochrane Collaboration does not endorse 
any particular instrument to assess the quality of non-randomized studies, such as cohort and case-
control studies. Instead, it recommends that researchers apply the same methods for quality assessment to 
non-randomized studies as they would for randomized trials but with additional consideration of bias 
from confounding.
16 
 In this review, since race or ethnicity was the exposure of interest, all studies had an 
observational design. Therefore, we adapted the Cochrane Collaboration’s tool to assess risk of bias in 
seven domains applicable to observational studies: selection bias, confounding, blinding of personnel, 
measurement bias, incomplete outcomes data, selective reporting, and other sources of bias (Appendix 
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2). One author (J.L) reviewed each study to determine whether there was low, high, or unclear risk of 
bias in each domain and provided an overall risk of bias rating based on the predominance of the 
domain-specific grades. For studies that received an equal number of “low” and “high” bias ratings, the 
same author determined the overall risk of bias by qualitatively assessing the likelihood that bias in the 
relevant domains would influence the study results.  
 
RESULTS 
Search results 
 Our searches identified 45 unique records, 33 of which were excluded after reviewing the 
abstract and title for inclusion and exclusion criteria (Figure 1). Most articles were excluded because the 
study population was not defined by receipt of IPCC (n=13) or the study did not aim to compare care 
processes or outcomes between patients of different races or ethnicities (n=13). Three out of 12 articles 
were excluded after full-text review either because the study population was not defined by receipt of 
IPCC (n=2) or the study did not aim to make comparisons between patients of different races or 
ethnicities (n=1). Nine articles met the inclusion and exclusion criteria described above (Figure 1).
17-25 
Study characteristics 
 All articles reported on observational studies (two prospective cohort, seven retrospective 
cohort) of patients who had received an IPCC in the acute care hospital setting. Five studies were 
conducted in urban, academic medical centers,
17-19,23,25
 while the rest were conducted in nonprofit health 
maintenance organization medical centers
20,21
 or community hospitals with teaching affiliations.
22,24
 
There was a wide range of geographic diversity with studies conducted in the northeastern Mid-
Atlantic,
19,25
 Southeast,
22
 Midwest,
23
 and western Mountain
18
 and Pacific
17,20,21,24
 regions. Sample size 
ranged from 161 patients to 3207 patients
 
(Table 1).
 
 Studies differed in which races/ethnicities they examined and how they categorized racial/ethnic 
groups. All but one study included the racial category of “white” or “Caucasian”; the remaining study 
compared Native American and non-Native American patients.
18
 Black patients were the most frequently 
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studied minority group (seven studies), followed by Hispanic or Latino patients (five studies) and Asian 
or Pacific Islander patients (four studies). Four studies included an “other” racial/ethnic category. All but 
one study
22
 excluded patients whose race or ethnicity was unknown. Five studies specified that patient 
race and ethnicity were self-reported either at hospital admission or at time of consultation.
17,18,20,21,25
 In 
four studies, race/ethnicity data was extracted from the electronic medical record (EMR), but the method 
of measuring race and ethnicity was unclear.
19,22-24 
 All studies measured clinical outcomes rather than palliative care processes or quality metrics. 
Hospice enrollment after IPCC was the most frequently measured primary outcome (six studies), 
followed by code status (five studies), and change in patient-reported pain level (two studies). Other 
primary outcomes included post-IPCC participation in a family meeting, time from admission to 
consultation, and hospital length of stay (Table 1). 
Quality of the evidence 
 Given the observational design, confounding was a common limitation, particularly for studies 
that did not examine the distribution of patient characteristics across racial/ethnic groups.
20,22,23
 Studies 
that did compare baseline characteristics included covariates such as age, gender, marital status, primary 
diagnosis, functional status, time from admission to consultation, reason for consultation, and baseline 
pain score. In general, white patients tended to be older than racial/ethnic minorities. Three studies 
adjusted for covariates that were substantially different between comparative groups
17,21,25
 (Table 2). 
High risk of selection bias was also common due to exclusion of patients with missing data, exclusion of 
patients with “unknown” or “other” race/ethnicity, and/or inclusion criteria that limited the study 
population to either pain-related or goals of care-related consultations only (Table 2). 
 None of the retrospective studies discussed measures taken to blind the personnel who extracted 
race/ethnicity and outcomes data from medical charts. However, lack of blinding was likely not a 
significant source of bias because the primary outcomes in all studies were binary or continuous 
variables that required minimal judgment from the outcome assessor. Overall, five studies had high risk 
of      bias
18-20,23,24
 and four studies had low risk of bias
17,21,22,25
 (Table 2).  
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Relationships between race/ethnicity and outcomes 
Hospice 
 Out of six studies that examined the association between race or ethnicity and hospice 
enrollment, two studies found a significant relationship between race or ethnicity and hospice enrollment 
at hospital discharge (Table 1). In a majority-Asian or Pacific Islander population, Bell et al. found that 
Asian, Pacific Islander, and Other ethnicity patients were more likely to be referred and discharged to 
hospice than white patients after adjusting for age, gender, Karnofsky Performance score, and pre-
consultation hospital days.
17
 Although the reasons underlying this trend were not well-understood, the 
authors noted that the association between ethnicity and hospice referrals was substantially reduced and 
became non-significant for Asians and Pacific Islanders after controlling for indication for consultation 
(plan of care vs. not plan of care). Thus, higher hospice referral rates in non-white patients were largely 
explained by their higher prevalence of referring physician requests for plan of care discussions, which 
then resulted in more discussions to clarify goals of care, treatment preferences, and disposition.
17 
 Fosler et al. found significant racial differences in hospice enrollment after IPCC among white 
black, Hispanic, and Asian patients. Among patients who received an IPCC, Asian and Hispanic patients 
had higher rates of post-consultation hospice enrollment (75% and 77%, respectively) than white and 
black patients (66% and 45%, respectively).
23
 Most likely, the small sample size with only five Asian 
patients, the population’s high illness severity (e.g. all patients were eligible for hospice), and the high 
risk of bias due to selection bias and confounding significantly limited the internal and external validity 
of the Fosler et al.’s findings.23 
 Four out of six studies found no racial/ethnic differences in hospice enrollment at hospital 
discharge among patients who received an IPCC. Marr et al. found no significant difference in 
disposition to hospice after IPCC between Native American and non-Native American patients.
18
 In a 
study of older adults who survived to hospital discharge, Enguidanos et al. compared hospice enrollees to 
non-hospice enrollees after IPCC and found similar odds of hospice enrollment in Latino, black, and 
Other ethnicity patients compared to white patients.
20
 Benton et al. found no difference in hospice 
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referral rates between black and white patients after a standardized counselor-based IPCC.
22
 Finally, 
Worster et al. used logistic regression models to find that race/ethnicity was not a significant predictor of 
disposition to hospice, time from admission to IPCC, or hospital length of stay in a comparison of white, 
black, Hispanic, Asian/Pacific Islander, and Other ethnicity patients.
25
 
 Notably, the three studies with a low risk of bias that compared hospice enrollment after IPCC 
across racial/ethnic groups either showed increased hospice enrollment after IPCC for minorities 
compared to white patients (i.e. Bell et al.
17
 found that Asian, Pacific Islander, and Other ethnicity 
patients were more likely to enroll in hospice after IPCC than white patients) or no significant 
racial/ethnic differences in post-IPCC hospice enrollment.
22,25
 Taken together, these three studies suggest 
that IPCC reduces existing racial/ethnic disparities in hospice enrollment. 
Code status 
 Overall, all five studies that examined associations between race or ethnicity and code status 
found substantial increases in Do Not Resuscitate (DNR) code status after IPCC across all racial and 
ethnic groups.
17-19,22,23
 Compared to before IPCC , the prevalence of DNR status after IPCC typically 
doubled. Most studies found that white patients were more likely to have DNR status than black or non-
white patients before consultation, but that difference diminished after consultation. For example, Marr 
et al. found that Native American (NA) patients were less likely to have a pre-consult DNR order than 
non-NA patients (23% vs. 38%), but there was no significant between-group difference in DNR orders 
after the consultation (62% vs. 64%).
18 
 Similarly, Zaide et al. found that white patients were more likely to have a pre-consult DNR 
order than black patients (25.7% vs. 11.3%), but the incidence of new DNR orders after IPCC did not 
differ significantly between white patients (33.7%) and black patients (28.9%).
19
 However, among 
patients who had Full Code status before IPCC, non-white patients (black, Hispanic, or Asian) were less 
likely to complete a DNR order after IPCC than white patients (32% vs. 45%, respectively).
19
 In a 
similar finding, Fosler et al. found that race/ethnicity was significantly associated with pre-consult code 
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status, with a higher prevalence of DNR orders in white and Hispanic patients compared to black and 
Asian patients. However, race/ethnicity was not significantly associated with DNR status after IPCC.
23 
 Bell et al. analyzed the change of code status to Do Not Attempt Resuscitation (DNAR), rather 
than comparing pre- and post-consult prevalence of DNAR status.
17
 Of note, this was the only study that 
controlled for covariates when analyzing the association between race/ethnicity and code status 
outcomes. They found that race/ethnicity (white, Asian, Pacific Islander, or Other) was not significantly 
associated with code status change in either direct comparisons or multiple logistic regression models 
controlling for age, gender, and indication for consultation.
17 
 Benton et al. was the only study with a low risk of bias that compared pre- and post-consult 
treatment preferences in black versus white patients. Compared to white patients, black patients were less 
likely to have chosen DNR (27.7% vs. 17.7%) or care and comfort only (CCO) (5.0% vs. 3.5%) prior to 
IPCC.
22
 After IPCC, there was substantial movement toward a preference for less aggressive care in both 
groups, with no significant post-IPCC difference in DNR status (43.8% of black patients compared to 
38.5% of white patients). However, white patients were still more likely to choose CCO compared to 
black patients (49.2% vs. 34.7%).
22 
Pain management outcomes 
 Two studies examined the association between race or ethnicity and pain reduction after 
IPCC.
21,24
 In a small study (n=161) with high risk of bias and a large proportion of Hispanic/Latino 
patients, Chung et al. examined the association between race/ethnicity and changes in pain level, 
assessed using the Visual Analogue Scale, after pain-related IPCC.
24
 They found that white, black, and 
Hispanic patients, but not Asian/Other patients, reported significant reductions in pain after pain-related 
IPCC compared to 24 hours before IPCC. Additionally, the authors found significant reductions in pain 
level at discharge compared to admission for white, Hispanic, and Asian/Other patients, but not for black 
patients. Despite these findings, there were no significant between-group differences in pain level change 
at any of the time point comparisons (Chung).  
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 In a larger study of older adults with low risk of bias and a similarly large proportion of Latino 
participants, Laguna et al. found that white, black, and Latino patients all reported significant reductions 
in numeric pain level after compared to before IPCC.
21
 After controlling for age, primary diagnosis of 
cancer, number of chronic conditions, and baseline pain level, there were no significant racial or ethnic 
differences in pain level before IPCC, two hours post-consult, or 24 hours post-consult. However, 
Latinos were 62% more likely than whites to report pain at hospital discharge.
21
 Thus, the only study 
with a low risk of bias that examined pain management outcomes suggests that IPCC improves pain 
control in all patient groups, but it is unclear whether IPCC reduces pain outcome disparities given that 
Latino patients were more likely than whites to report pain at discharge.
21
 
 
DISCUSSION 
 In this review, we identified nine observational studies that examined associations between 
patient race or ethnicity and outcomes of specialty palliative care consultation in the inpatient setting. 
Overall, after IPCC patients across all racial and ethnic groups experienced increases in hospice 
enrollment and preference for DNR code status, as well as reductions in pain level. The most noticeable 
and consistent finding was a lower rate of DNR status in racial/ethnic minorities, particularly black 
patients, compared to non-Hispanic white patients before consultation, followed by similar rates of DNR 
status after consultation (Table 1). Additionally, despite disproportionately low hospice use among 
minority patients in the general population, hospice enrollment after IPCC was either similar across 
racial/ethnic groups
22,25
 or increased in minority patients.
17 
In sum, IPCC appeared to have a leveling 
effect on code status preferences and increased minority patients’ access to hospice services. 
 Extensive research has demonstrated that black patients are more likely than non-Hispanic 
whites to choose life-sustaining treatments near the end of life,
4,7,26,27
 while there is mixed evidence on 
the treatment preferences of other racial minorities. In most studies, black and Hispanic/Latino patients 
are also less likely than non-Hispanic whites to complete formal advance directives due to a combination 
of complex and interrelated factors, including cultural and spiritual differences, disparities in health care 
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access, distrust of health care providers, and different family decision-making processes.
28,29
 None of 
these studies address the quality of informed decision-making resulting in these stated preferences, while 
the patients included in this systematic review all had IPCC support for discussion and information to 
guide treatment choices.  Although the studies in this review evaluated code status and preference for 
comfort-oriented care only, rather than advance directive completion, the similar rates of post-
consultation DNR status across racial/ethnic groups suggest that seriously ill minority patients may 
express a preference for less aggressive care after palliative care consultation in the inpatient setting. One 
hypothesis is that palliative care specialists’ expertise in communication about end-of-life care decision-
making results in greater understanding and trust of treatment plans that prioritize quality of life over 
longevity among all patients, regardless of race/ethnicity. 
 In the three low-risk of bias studies comparing hospice enrollment between racial/ethnic groups, 
two studies
22,25
 found no association between race/ethnicity and hospice enrollment rates, and one study 
found that Asian, Pacific Islander, and Other patients were more likely to enroll in hospice after IPCC 
than white patients.
17
 More severe disease states in Asian and Pacific Islander patients could have 
contributed to higher hospice enrollment rates. Studies using Surveillance, Epidemiology, and End 
Results (SEER) Program data have indicated that Native Hawaiian, Pacific Islander, and Micronesian 
patients tend to present with more advanced stages of cancer and have higher risks of cancer death than 
non-Hispanic white patients.
30,31
 Asians and Pacific Islanders are under-represented in disparities 
research, and more investigation is needed to explain differences in hospice enrollment rates after IPCC 
in diverse populations. 
 There is a striking distinction between minority patients’ similar or higher post-consultation 
hospice enrollment rates in these studies and the racial disparities in hospice use in the general 
population after controlling for demographic, socioeconomic, and diagnostic covariates. Among 
Medicare beneficiaries who died in 2010, 46% of whites enrolled in hospice, compared to 34% of black 
Americans, 37% of Hispanic/Latinos, and 31% of Native Americans.
32
 In a large study of Medicare and 
Medicaid dual-eligible nursing home residents, black residents were less likely to use hospice than white 
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residents among those without a cancer diagnosis, although this difference was not found among patients 
without a cancer diagnosis.
11
 Another national study with over 1.8 million participants found that, after 
controlling for age, sex, cause of death, and state of residence, white decedents were more likely to use 
hospice in the last year of life than black decedents (29% vs. 22%).
12
 Less research has focused on 
hospice use disparities affecting other minority groups. The predominance of studies in this review that 
found similar post-consultation hospice enrollment rates across racial/ethnic groups aligns with the 
finding of similar post-consultation rates of DNR status, adding to the evidence that IPCC exerts a 
balancing effect by helping most patients pursue less aggressive care, irrespective of race/ethnicity, and 
thus reduces the disparities by increasing minority patients’ access to hospice services. 
 Finally, two studies in our review suggest that all patients, including white, black, 
Hispanic/Latino, and Asian/Other patients, experience significant reductions in pain level after IPCC.
21,24
 
Most comparisons found no significant differences in pain level or change in pain score between 
racial/ethnic groups before or after consultation. One exception was that in a low-risk of bias, 
retrospective study of older adults who received an IPCC, Latino patients were 62% more likely to report 
pain at hospital discharge than whites.
21
 Further research is needed to determine whether this disparity 
exists in other IPCC settings and, if so, to elucidate the reasons underlying Latinos’ relatively high pain 
level at discharge. Across multiple care settings and types of pain, most but not all studies show that 
black and Hispanic/Latino patients receive less adequate pain assessment and less effective pain 
treatment compared to non-Hispanic white patients.
3,33
 Research on pain-related disparities affecting 
other minority groups, including Asian patients, is minimal. Reduced access to care and to opioid 
medications, implicit provider bias, and variation in patients’ attitudes and social support may contribute 
to inequities in pain management.
3,33
 Although more investigation is needed to clarify the effects of IPCC 
on longer-term pain management and pain-related function and quality-of-life, our review points to IPCC 
as a potential intervention to reduce racial and ethnic disparities in pain level among patients with serious 
illnesses.  
Strengths and Limitations 
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 In this review, we examined whether patient race or ethnicity is associated with palliative care 
outcomes or processes in the inpatient specialty palliative care setting. To our knowledge, no other 
systematic review has addressed this question. We identified only nine studies that met our inclusion and 
exclusion criteria, demonstrating a gap in research on racial/ethnic disparities affecting patients seen by 
inpatient palliative care specialists. Additionally, the studies in this review covered a wide range of 
geographic settings with vastly different demographic profiles. By comparing studies conducted in 
different areas, we were able to observe common versus location-specific trends in outcomes by patient 
race or ethnicity. 
 Our review has several important limitations. First, we used a narrow search strategy to identify 
only studies whose primary aim was to determine associations between patient race/ethnicity and 
outcomes or care processes (Figure 1). Thus, we did not include studies that evaluated the effects of 
IPCC in certain populations and included secondary analysis of associations between patient race or 
ethnicity and outcomes. Including such studies would broaden the review to include larger, multi-center 
studies, which would strengthening the review’s power to detect racial and ethnic trends in patient 
experience and utilization outcomes after IPCC. 
 Second, studies were highly heterogeneous with respect to racial and ethnic groups included, 
outcomes, consultation characteristics, and methodological quality and rigor, making it difficult to draw 
generalizable conclusions. For example, the only study that found higher hospice enrollment rates in 
persons of color compared to white patients was located in Hawaii in a majority-Asian and Pacific 
Islander population.
17
 These results may not be applicable to regions with different demographic profiles. 
Furthermore, some studies modified the typical IPCC intervention by increasing cultural competency 
training,
18
 using standardized counselor-based assessment and support methods,
22
 or separating goals-of-
care consultations from pain-related consultations in analysis.
23,24
 These studies may have limited 
external validity in settings with traditional IPCC elements and when looking at consultations with a 
variety of reasons for referral. 
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 Finally, we limited our review to studies whose study populations consisted of patients who 
received inpatient specialty palliative care consultation in an acute care hospital. Thus, we excluded 
studies that examined racial or ethnic differences in access to IPCC among hospitalized patients. Even if 
patients seen by an inpatient palliative care team have similar clinical outcomes, disparities may still 
exist at the level of access to IPCC. For example, Sharma et al. evaluated the association between 
race/ethnicity and rates of IPCC in patients with metastatic cancer and found that, compared to whites, 
African American patients actually had a greater likelihood of receiving an IPCC (OR 1.21, 95% CI, 
1.01 to 1.44) after adjusting for insurance, hospitalizations, marital status, and illness severity.
34
 
However, IPCC typically occurred close to death regardless of race/ethnicity, limiting its potential to 
change the course and patient experience of end-of-life care.
34
 Determining associations between 
race/ethnicity and IPCC rates among hospitalized patients is essential to understand IPCC’s capacity to 
reduce racial and ethnic disparities in end-of-life care outcomes including symptom management, 
hospice use, and satisfaction with communication and decision-making.  
Future Research Directions: 
 Current research on racial/ethnic disparities in IPCC practices or outcomes lacks the large, multi-
site, prospective cohort studies needed to provide strong evidence of meaningful similarities and 
differences between patients of different races and ethnicities. Large cohort studies spanning a wide 
geographic radius could help clarify disparities that are widespread versus context-specific. Additionally, 
most research has focused on comparisons between black, white, and Hispanic/Latino patients, while 
analyses that include Asian or patients of other races and ethnicities suffer are limited by small sample 
sizes. Conducting large-scale studies would help increase the sample sizes of all minority groups and 
enable meaningful between-group comparisons. 
 Non-standardized measurement of race and ethnicity and varying definitions of race and 
ethnicity are inherent limitations in disparities research. All studies in this review used the 1997 Office of 
Management and Budget (OMB) race and ethnicity categorizations used in the U.S. census, which 
include at a minimum five race categories (American Indian or Alaska Native, Asian, Black or African 
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American, Native Hawaiian or Other Pacific Islander, and White) and two ethnicity categories (Hispanic 
or Latino and Not Hispanic or Latino).
35
 In most studies, patients self-reported their race and ethnicity; 
however, four studies extracted race and ethnicity data from the electronic medical record,
19,22-24
 and it 
was unclear how race and ethnicity were measured in those studies. In 2016, as part of an ongoing 
review of the 1997 standards, the OMB requested public comment on issues including the use of separate 
questions to measure race and ethnicity, the classification of a new Middle Eastern and North African 
category, and terminology used for race and ethnicity classifications.
36
 The ever-changing lines defining 
racial and ethnic categories, as well as the increasingly diverse and mixed U.S. population, make it 
difficult to detect real associations between race/ethnicity and health care practices and outcomes.  
 Confounding is another common problem limiting research findings on health care disparities. 
Only three studies in this review adjusted for possible confounders in their analysis.
17,21,25
 These studies 
did not control for education level and socioeconomic status, which are typically associated with race 
and ethnicity. However, adjustment for socioeconomic status indicators in regression analyses can 
obscure complex interactions between race/ethnicity and socioeconomic status. For example, multiple 
studies have demonstrated that socioeconomic differences do not explain all health inequalities between 
black and non-Hispanic white patients.
37
 Additionally, since an individual’s race/ethnicity is essentially 
determined at birth and influences the individual’s interactions in all social institutions, including 
education, employment, health care, and the political system, socioeconomic status may act as a mediator 
of the association between race/ethnicity and health outcomes, rather than a confounder. Stratifying 
analyses by relevant covariates could help clarify interactions between race, gender, socioeconomic 
status, and other key characteristics in influencing palliative care practices and outcomes. 
 Additionally, although code status, hospice enrollment, and pain level are important IPCC 
outcomes, researchers should expand the range of clinical outcome variables to include patient- or 
family-reported outcomes related to symptom control, functional status, quality-of-life, and satisfaction 
with care. Several studies in this review suggested that IPCC narrowed the gap between black and white 
patients in DNR code status
18,19,22,23
 and hospice referrals.
17,22,25
 Future studies should investigate this 
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trend further to determine which features of IPCC are associated with similar post-consultation 
preference for DNR orders irrespective of race, whether IPCC is also associated with reduced racial 
disparities in advance care planning discussions and documentation, and how IPCC differs from other 
clinical interventions with respect to communication strategies, decision-making processes, family 
involvement, and other elements of discussions about end-of-life care. 
 Finally, our review did not identify any studies that examined racial/ethnic differences in care 
processes or practices. Development of palliative care practice guidelines and quality measures has 
accelerated in the last decade with the growth of Nation Quality Forum (NQF)-endorsed palliative care 
quality measures and the American Academy of Hospice and Palliative Medicine’s Measuring What 
Matters portfolio of recommended performance measures for quality improvement.
38,39
 In a recent study 
using data from an electronic quality monitoring system, Kamal et al. found that conformance with 
certain quality measures related to symptom assessment was associated with higher quality of life among 
patients with cancer.
40
 Among patients seen by an IPCC team, it would be interesting to investigate 
whether race/ethnicity is associated with adherence to quality measures, including assessment of physical 
and emotional symptoms, appropriate pain and dyspnea treatments, discussion of spiritual/religious 
concerns, and discussion of the patient’s treatment preferences and surrogate decision-maker.39 
 
CONCLUSIONS 
 Although there is clear evidence of health care disparities in palliative and end-of-life care, 
particularly in the areas of hospice enrollment, advance care planning, and pain management, our review 
suggests that most patients move toward less aggressive care after IPCC, with substantial increases in 
post-consultation DNR code status and hospice enrollment compared to baseline, irrespective of race or 
ethnicity. Pain levels after IPCC were also similar between patients of different races/ethnicities. These 
findings are important because they point toward IPCC as an effective tool to neutralize racial/ethnic 
disparities in patients with life-threatening illnesses. While we need larger studies to illuminate these 
trends and to examine other associations between race/ethnicity and IPCC practices and outcomes, 
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clinicians and researchers should recognize the possibility of bridging the inequities in palliative and 
end-of-life care by connecting patients to palliative care specialists during hospital admission.  
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Figure 1. Search process to identify studies examining associations between race/ethnicity and care 
processes or outcomes among patients who received an inpatient specialty palliative care consultation.
a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through database searches  
(n = 92) 
MEDLINE: 42 
CINAHL: 22 
EMBASE: 28 
 
 
47 duplicates removed 
Records screened for eligibility 
(n = 45) 
(n =   ) 
Full-text articles reviewed 
(n = 12) 
Studies included in qualitative synthesis  
(n = 9) 
Records excluded based on abstract, title, or both 
 (n = 33) 
3-Not located in United States or Canada 
4-Not experimental, quasi-experimental, or observational design 
13-Study population not defined by inpatient palliative care consultation 
13-Did not aim to compare patients of different races/ethnicities  
Full-text articles excluded  
(n = 3) 
2-Study population not defined by inpatient palliative care consultation 
1- Did not aim to compare patients of different races/ethnicities 
a. When screening records, inclusion and exclusion criteria were applied according to the following hierarchy: location and article 
type (exclusion criteria); study design; study population defined by receipt of inpatient palliative care consultation; study aim to 
compare patient characteristics, care processes, and/or outcomes between patients of different races or ethnicities. Reasons for 
exclusion reflect the first missed criterion in that hierarchy. 
 24 
 
Table 1. Characteristics of studies examining racial/ethnic differences among patients who received an 
inpatient specialty palliative care consultation. 
Reference Design & 
Setting 
Aims Population Measures Results 
Bell et al. 
(2011)
17 
Prospective 
cohort; large 
academic 
medical center 
in Hawaii. 
Determine if 
ethnicity (white, 
Asian, Hawaiian/ 
Pacific Islander, or 
Other) is associated 
with hospice 
referrals and code 
status changes after 
IPCC. Determine 
whether consultation 
intensity affects this 
association. 
1362 adult 
cancer patients 
(29% white, 
45% Asian, 
22% Pacific 
Islander, 5% 
Other) 
Self-reported 
race/ethnicity at 
admission. 
 
IPCC team recorded, 
changes in code status, 
discharge to hospice, and 
reasons for consult. 
Hospice referral & 
enrollment rates in 
Asian, Pacific Islander, 
and Other ethnicity 
patients were higher than 
in white patients 
(AOR 1.46–2.34). 
 
Ethnicity was not 
significantly associated 
with code status changes. 
Marr et al. 
(2012)
18 
Prospective 
cohort; large 
academic 
medical center 
in NM. 
Determine if Native 
American (NA) and 
non-Native 
American patients 
have similar rates of 
DNR status and 
family meeting 
participation after 
IPCC. 
413 new 
patients  
(13% NA, 87% 
non-NA) 
Self-reported 
race/ethnicity at 
admission. 
 
IPCC team recorded 
code status, pre- and 
post-consult family 
meetings, and 
disposition. 
No significant 
differences between NA 
and non-NA patients in 
post-consult DNR status, 
increase in family 
meeting participation, or 
disposition to hospice. 
Zaide et al. 
(2013)
19 
Retrospective 
cohort; 
academic 
medical center 
in NY.  
 
Examine 
racial/ethnic 
differences in DNR 
and/or DNI code 
status after IPCC 
between black, 
white, Asian, and 
Hispanic patients. 
400 patients 
(47% white, 
35% black, 
11% Asian, 7% 
Hispanic) 
Race/ethnicity data 
extracted from EMR. 
 
Recorded data on code 
status pre- and post-
IPCC from EMR. 
Compared to whites, 
non-white patients were 
less likely to complete a 
DNR/DNI after IPCC. 
Black patients were less 
likely to have DNR/DNI 
status before IPCC, but 
no significant difference 
in DNR/DNI completion 
post-IPCC.   
Enguidanos 
et al. 
(2013)
20 
Retrospective 
cohort; 
nonprofit 
HMO medical 
center in 
southern CA. 
Determine if 
ethnicity (white, 
black, Latino, or 
Other) is associated 
with hospice 
enrollment after 
IPCC. 
408 patients 
aged ≥65 years, 
survived to 
discharge (43% 
white, 26% 
Latino, 23% 
black, 9% 
Other) 
Self-reported ethnicity at 
consultation. 
 
IPCC team recorded 
discharge disposition. 
Other data collected 
from consult checklist, 
databases, and EMR. 
Similar odds of hospice 
enrollment after IPCC 
among Latino (OR 0.67), 
black (1.24), and Other 
ethnicity patients (0.78) 
compared to white 
patients. 
Laguna et al. 
(2014)
21 
Retrospective 
cohort; 
nonprofit 
HMO medical 
center in 
southern CA. 
Examine 
racial/ethnic 
differences in pain 
level after IPCC 
between whites, 
blacks, and Latinos. 
385 patients 
aged ≥65 years 
(46% white, 
29% Latino, 
25% black) 
Self-reported 
race/ethnicity at 
consultation. 
 
Patients reported pain 
level using 11-point 
Number Rating Scale 
before consult, 2 and 24 
hours post-consult, and 
at discharge. IPCC RNs 
collected pain data. 
Whites, blacks, and 
Latinos all reported 
significant pain 
reductions after IPCC. 
Latino patients were 
62% more likely than 
whites to report pain at 
discharge. 
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Benton et al. 
(2015)
22 
Retrospective 
cohort; large 
community 
teaching 
hospital in 
GA. 
Determine if race 
(white vs. black) is 
associated with 
changes in treatment 
preferences and 
hospital disposition 
after a standardized 
counselor-based 
IPCC. 
2843 
consultations, 
patients aged 
>18 years (50% 
white, 35% 
black, 15% 
unknown) 
Race determined at 
hospital registration. 
 
Data on preferences (full 
code, DNR, or CCO) 
before IPCC and at 
discharge collected from 
EMR and IPCC 
database. 
Whites more likely to 
have DNR or CCO status 
before IPCC, and more 
likely to have CCO 
status after IPCC than 
black patients. Both 
groups had large 
increases in DNR & 
CCO status. No 
significant difference in 
hospice enrollment rates. 
Fosler et al. 
(2015)
23 
Retrospective 
cohort; large 
Midwestern 
academic 
medical center.  
Determine if 
race/ethnicity 
(white, black, or 
Hispanic) is 
associated with pre- 
and post-IPCC DNR 
status and hospice 
enrollment. 
199 patients 
(45% white, 
38% black, 
15% Hispanic, 
2% Asian) 
Race/ethnicity data 
extracted from EMR. 
 
Collected data on pre- 
and post-IPCC code 
status and hospice 
enrollment from EMR. 
 
Significant differences in 
pre-consult DNR status 
(Hispanic: 47%, white: 
46%, black: 27%, Asian: 
25%). No significant 
differences in DNR 
status after IPCC. 
Significant differences in 
post-IPCC hospice 
enrollment (Hispanic: 
77%, Asian: 75%, white: 
66%, black: 45%). 
Chung et al. 
(2016)
24 
Retrospective 
cohort; 
community 
teaching 
hospital in 
Fresno, CA. 
Examine 
racial/ethnic 
differences in pain 
level after pain-
related IPCC 
between Caucasian, 
African-American, 
Hispanic, and 
Asian/Other 
patients. 
161 patients 
(48% 
Caucasian,  
33% Hispanic, 
9% African-
American, 9% 
Asian/Other) 
Race/ethnicity data 
extracted from EMR. 
Categorized into four 
groups. 
 
Patients reported pain 
level using Visual 
Analog Scale. Created 4 
scores by averaging pain 
scores in the following 
periods: first 24 hours of 
admission, 24 hours 
before IPCC, 24-48 
hours after IPCC, and 24 
hours before discharge. 
Caucasian, African-
American, and Hispanic 
patients had significant 
pain reductions after 
IPCC compared to 24 
hours before IPCC. 
Caucasian, Hispanic, and 
Asian/Other patients had 
significant pain 
reductions from 
admission to discharge. 
 
No significant pain score 
differences between 
racial groups. 
Worster et 
al. (2017)
25 
Retrospective 
cohort; large 
academic 
medical center 
in 
Philadelphia, 
PA. 
Determine if 
race/ethnicity 
(white, black, 
Hispanic/Latino, 
Asian/Pacific 
Islander, or Other) is 
associated with time 
from admission to 
IPCC, disposition to 
hospice, or hospital 
LOS after IPCC. 
3207 patients 
(65% white, 
27% black, 3% 
Hispanic, 3% 
Asian/Pacific 
Islander, 1% 
Other) 
Self-reported 
race/ethnicity on 
admission. Recoded into 
5 groups. 
 
Data extracted from 
EMR. Calculated time 
from admission to IPCC 
and hospital LOS. 
Disposition recoded as 
hospice vs. not hospice.  
Race/ethnicity was not a 
significant predictor of 
time to IPCC, LOS, or 
disposition to hospice. 
 
Abbreviations: IPCC, inpatient palliative care consultation; EMR, electronic medical record; OR, odds ratio; AOR, adjusted 
odds ratio; NM, New Mexico; HMO, health maintenance organization; CA, California; RNs, nurses; CCO, comfort care only; 
LOS, length of stay. Race/ethnicity percentages are rounded to whole numbers. 
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Table 2. Risk of bias assessment for reviewed studies.
a
 
Reference Selection 
bias 
Confounding Blinding Measurement 
bias 
Attrition 
bias 
Reporting 
bias 
Other sources 
of bias 
Overall risk 
of bias 
         
Bell et al. 
(2011)  
low low high low low low low low 
Marr et al. 
(2012) 
low high high low low high high high 
Zaide et al. 
(2013) 
high high unclear unclear low high high high 
Enguidanos et 
al. (2013) 
high high unclear low low high high high 
Laguna et al. 
(2014) 
high low unclear low low low low low 
Benton et al. 
(2015) 
low high unclear unclear low low high low 
Fosler et al. 
(2015) 
high high unclear unclear low low high high 
Chung et al. 
(2016) 
high high unclear unclear low low high high 
Worster et al. 
(2017) 
high low unclear low low low low low 
 
a. For all studies, blinding of participants was impossible because race/ethnicity was the exposure variable. For prospective 
cohort studies, risk of bias due to concerns about blinding was considered high because the palliative care clinicians knew each 
participant’s race/ethnicity prior to measuring outcomes. For retrospective cohort studies, risk of bias was considered unclear if 
there was no information about blinding of study personnel who collected data. 
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Appendix 1. Search strategies for systematic review. 
 
MEDLINE (via PubMed) search: 
(palliative care OR "palliative medicine"[MeSH]) AND ("inpatient palliative care" OR "palliative care 
consult" OR "palliative care consultation" OR "specialty palliative care") AND (“healthcare 
disparities”[MeSH] OR disparities OR race OR ethnicity OR "African Americans") 
 
CINAHL (via EBSCO) search: 
(palliative care OR "palliative medicine"[MW]) AND ("inpatient palliative care" OR "palliative care 
consult" OR "palliative care consultation" OR "specialty palliative care") AND (“healthcare 
disparities”[MW] OR disparities OR race OR ethnicity OR "African Americans") 
 
EMBASE search: 
'palliative care' OR 'palliative medicine'/exp AND ('inpatient palliative care' OR 'palliative care 
consult' OR 'palliative care consultation' OR 'specialty palliative care') AND ('healthcare disparities'/exp 
OR disparities OR race OR ethnicity) 
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Appendix 2. Cochrane Collaboration’s tool to assess risk of bias, adapted for observational studies. 
Domain Support for judgement Review authors’ judgement 
Selection bias Describe methods used to screen for, 
recruit, and retain participants and assess 
whether these methods should produce 
comparable groups.  
 
Selection bias due to 
systematic error in the 
methods of selecting or 
retaining participants.  
Confounding Describe all methods used to consider 
possible confounders, assess the balance 
between comparator groups with respect 
to confounding factors, and describe 
measures to minimize, adjust for, or 
explain their decision not to adjust for 
confounding.  
 
Bias due to imbalance of 
confounders that distorts the 
association between the 
exposure and outcome. 
Blinding of personnel 
(Performance bias) 
Describe all measures used, if any, to 
blind study participants and personnel 
from knowledge of which intervention a 
participant received. Provide any 
information relating to whether the 
intended blinding was effective. 
 
Performance bias due to 
knowledge of the allocated 
interventions by participants 
and personnel during the 
study. 
Measurement bias Describe all measures used, if any, to 
blind outcome assessors from knowledge 
of which intervention a participant 
received. Provide any information 
relating to whether the intended blinding 
was effective. Evaluate the likelihood of a 
systematic error in measurement. 
 
Detection bias due to 
knowledge of the allocated 
interventions by outcome 
assessors or due to another 
form of systematic error in 
measurement. 
Incomplete outcome data  
(Attrition bias) 
Describe the completeness of outcome 
data for each main outcome, including 
attrition and exclusions from the analysis. 
State whether attrition and exclusions 
were reported, the numbers in each 
intervention group (compared with total 
randomized participants), reasons for 
attrition/exclusions where reported, and 
any re-inclusions in analyses performed 
by the review authors. 
 
Attrition bias due to amount, 
nature or handling of 
incomplete outcome data. 
Selective reporting  
(Reporting bias) 
State how the possibility of selective 
outcome reporting was examined by the 
review authors, and what was found. 
 
Reporting bias due to selective 
outcome reporting. 
Other sources of bias State any concerns about bias not 
addressed in the other domains in the 
tool. 
 
Bias due to problems not 
covered elsewhere in the table. 
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Original Investigation: Quality measure adherence and clinical outcomes in black versus white 
patients seen by an inpatient specialty palliative care consultation team 
 
INTRODUCTION 
 Racial and ethnic disparities in health care access, quality, and outcomes are well-documented 
across a wide range of treatment settings and diseases, including serious illnesses such as cancer, 
cardiovascular disease, and end-stage renal disease.
1
 There is growing evidence that similar disparities 
persist in palliative and end-of-life care.
2
 Compared to non-Hispanic whites, racial and ethnic minorities 
are less likely to enroll in hospice across geographic regions.
2-6
. Black and Hispanic patients are also 
more likely to be hospitalized and receive aggressive care in the last six months of life.
2,7
 Although the 
etiology of this trend is likely multifaceted, with socioeconomic and cultural factors contributing, no 
unifying explanation exists.
7,8
 There is extensive literature describing racial and ethnic disparities in the 
assessment and management of acute, chronic, and cancer-related pain.
9-11
 In some studies, compared to 
non-Hispanic whites, black patients and family members have reported decreased satisfaction with 
overall end-of-life care quality,
8
 more difficulties communicating and sharing decision-making with 
providers,
12,13
 and lower rates of advance care planning and advance directive completion.
14-16
 
 Although racial and ethnic differences in end-of-life care choices and health care utilization 
clearly exist, research on disparities in palliative care quality is primarily limited to analyses of patient 
and family surveys in hospice settings. There is mixed evidence on hospice outcomes among 
black/African American patients compared to non-Hispanic white patients. In an analysis of survey data 
from 819 hospices, compared to non-Hispanic white respondents, African American family members 
were less likely to rate the overall quality of hospice care as “excellent” or very good” (odds ratio (OR) = 
0.7, 95% confidence interval (CI) = 0.6-0.8) and more likely to express concerns about patients’ unmet 
needs in pain control, dyspnea management, and emotional support.
17
 However, there was no difference 
in family members’ overall satisfaction ratings.17 In contrast, another study found no difference in 
satisfaction with hospice services and outcomes between African American and white patients and 
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families in a large hospice organization.
18
 Research is lacking on quality of care disparities in non-
hospice palliative care settings. 
 As hospice and specialty palliative care services follow the national movement toward quality 
improvement and high-value care, researchers and policy-makers have developed systematic approaches 
to measuring and evaluating palliative care quality. The Institute of Medicine (IOM), National Institute 
of Health (NIH), and Agency for Health Care Research and Quality (AHRQ) have recognized the need 
to prioritize rigorous research in palliative care quality measurement and improvement.
18-20
 In 2004, the 
National Consensus Project (NCP) developed practice guidelines and delineated eight core domains of 
palliative care: Structure and Processes of Care, Physical Aspects of Care, Psychological and Psychiatric 
Aspects of Care, Cultural Aspects of Care, Social Aspects of Care, Care of the Imminently Dying, Care 
at the End of Life, and Spiritual, Religious, and Existential Aspects of Care.
21
 The NCP led the way for 
multiple organizations to develop measures to evaluate palliative care quality in each of these domains.  
 In 2012, the National Quality Forum (NQF) endorsed 14 measures for accountability and quality 
improvement in palliative and end-of-life care services.
22
 Seven of these measures are calculated using 
data collected through the Hospice Item Set (HIS), which is part of the Center for Medicare and 
Medicaid Services’ (CMS) mandated Hospice Quality Reporting Program (HQRP). Although non-
hospice palliative care providers are not yet required to measure and report on quality, mandated 
reporting may be on the horizon as our health care system establishes payment models based on 
performance. Additionally, the American Association of Hospice and Palliative Medicine (AAHPM) and 
Hospice and Palliative Nursing Association (HPNA) implemented the Measuring What Matters (MWM) 
project to develop a consensus set of ten indicators of palliative care quality.
23 
 Quality measures can also help identify aspects of palliative care that lead to improved 
outcomes. For example, in a recent study evaluating the relationship between conformance with 18 
palliative care quality measures and quality of life, conformance to comprehensive screening of 
symptoms and assessment of emotional well-being were associated with higher patient-reported quality 
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of life.
23
 Standardized quality measurement can also illuminate any differences that exist in palliative 
care practice by patient race/ethnicity, primary diagnosis, socioeconomic status, and other characteristics.  
 Inpatient palliative care consultation may have the potential to reduce racial and ethnic 
disparities in hospice enrollment, satisfaction with end-of-life care, and health care utilization. For 
patients with serious illness, a hospitalization may act as a sentinel event and opportunity to enhance 
attention to aspects of palliative care and offer treatment options. For this assumption to be true, specialty 
palliative care clinicians must offer high-quality care in an equitable way. To address this question, we 
compared patient characteristics, adherence to palliative care quality measures, and selected clinical 
outcomes between encounters for seriously ill black/African American and white/Caucasian patients on 
an inpatient specialty palliative care consultation service. 
 
METHODS 
Setting and Patient Population 
 Patients were included in our study if they were seen by the inpatient specialty palliative care 
consultation service between July 1, 2014 and June 30, 2015 at UNC Hospitals in Chapel Hill, NC. This 
public academic medical center provides all levels of acute inpatient care primarily to patients residing in 
central North Carolina, as well as referrals from other regions. During the study period, the palliative 
care service consisted of Hospice and Palliative Medicine board-certified attending physicians, Hospice 
and Palliative Care Nursing certified nurse practitioners, and a social worker, all with expertise in 
palliative care. Attending or resident physicians referred patients to the palliative care team from a 
variety of primary services, including general medicine, geriatrics, oncology, and specialty surgery 
services.  
 We defined all palliative care consultations for a patient during a unique hospital admission as a 
“clinical encounter,” which served as the unit for analysis. Some patients had multiple clinical 
encounters, each during a different hospital admission. Clinical encounters typically consisted of a 
history and physical conducted by a palliative care attending physician or nurse practitioner, with 
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subsequent follow-up visits until the patient was discharged from the hospital and/or the patient’s 
palliative care needs were satisfied from the standpoint of the specialty service.   
Data Source and Variables 
 We used an electronic quality monitoring system, the Quality Data Collection Tool-Palliative 
Care (QDACT-PC), to collect data on patient and encounter characteristics, quality measures, and 
encounter outcomes from medical records. QDACT-PC was originally designed as a provider-entered 
standardized data collection system with demonstrated feasibility in community-based palliative care.
24
 
However, due to workflow constraints in the inpatient setting, we implemented QDACT-PC to 
retrospectively collect data from patient medical records. For each clinical encounter, one trained 
assistant abstracted information from the medical record to complete a QDACT-PC form. We also used a 
separate database maintained by the palliative care consultation service that documents patient 
identification information, advanced care planning status and outcomes, changes in the treatment plan, 
and presence of dementia for all clinical encounters.   
 We analyzed de-identified data from the QDACT-PC and consultation service databases for all 
clinical encounters for black/African American and white/Caucasian patients seen on the inpatient 
specialty palliative care consultation service from July 1, 2014 through June 30, 2015. Data on race was 
collected as recorded in the electronic medical record, which typically represents the medical record 
account creator’s presumption of the patient’s race unless the account creator is uncertain and asks a 
patient to self-report. Race categories available in the medical record included black/African American 
(“black”), white/Caucasian (“white”), Asian, American Indian/Alaska Native, Other, or Unknown. 
Ethnicity categories included only Hispanic/Latino or not Hispanic/Latino. After identifying only two 
clinical encounters for white patients with Hispanic/Latino ethnicity during the study period, we decided 
to include clinical encounters for all black and white patients regardless of ethnicity in analysis, 
hypothesizing that patients labeled as white race with Hispanic/Latino ethnicity might resemble white 
patients more than other Hispanic/Latino patients and should thus be included in the former category.  
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 Baseline variables from the time of initial visit of the clinical encounter included patient age, 
gender, marital status, primary diagnosis for consultation (the primary life-limiting illness addressed by 
the palliative care service, categorized by disease type: Cancer, Cardiovascular, Pulmonary, 
Gastrointestinal, Renal, Neurologic, Infectious, or Other), 30-day hospital readmissions prior to current 
hospitalization (none vs. at least 1 readmission), presence of dementia, verbal or numeric reported pain 
level (none or mild = 0-3, moderate = 4-6, or severe = 7-10), code status (Full Code, Do-Not-
Resuscitate/Do-Not-Intubate (DNR/DNI), or Code with Limitations), presence of a prior advance 
directive, and treatment plan (primarily disease-directed, mixture of disease-directed and palliative, or 
primarily palliative) . We also included functional status based on the Palliative Performance Scale (0-
30%, 40-60%, or 70-100%), as this is routinely reported in clinical palliative care documentation. The 
Palliative Performance Scale (PPS) is a validated tool to measure the global functional level of seriously 
ill patients based on five observer-rated domains: ambulation, activity level and evidence of disease, self-
care, intake, and level of consciousness.
25
 The PPS has prognostic value in predicting outcomes and 
length of survival in hospitalized palliative care patients.
25
 The treatment plan was characterized as 
primarily disease-directed, primarily palliative, or mixed by the research assistant based on information 
about goals of care and treatment choices documented in the palliative care notes. Other variables 
reflecting the entire clinical encounter included timing of admission, palliative care consultation and 
discharge. 
 For each clinical encounter, we calculated adherence with seven quality measures from the NQF 
portfolio of Palliative Care and End-of-Life Care Measures,
22
 selected based on the availability of valid, 
reliable data for each measure. The seven quality measures selected were: Pain Screening, Pain 
Assessment, Dyspnea Screening, Dyspnea Treatment, Bowel Regimen with Opioid, Treatment 
Preferences, and Spiritual/Religious Concerns (Table 1). These measures were originally identified and 
specified in the PEACE project,
26
 and four of the measures (Dyspnea Screening, Dyspnea Treatment, 
Treatment Preferences, and Spiritual/Religious Concerns) are also included in the AAHPM’s Measuring 
What Matters (MWM) consensus set.
23
 We used the numerator and denominator specifications defined 
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by the measure developers in the most recent NQF endorsement review.
27
 We also assessed adherence to 
a composite measure based on the specifications for the HQRP’s Hospice Comprehensive Assessment 
measure, which calculates the percentage of patients who received all seven care processes reflected in 
the aforementioned quality measures. In addition to the above quality measures, we examined four 
clinical encounter outcomes of interest: completion of a new advance directive, referral to hospice, 
change in treatment plan to a less aggressive plan, and new Do Not Resuscitate (DNR) order (Table 1). 
Statistical Analysis 
 For all variables described above, we calculated means for continuous variables and percentages 
for categorical variables to compare clinical encounters for black patients to clinical encounters for white 
patients during the year-long study period. To avoid the high likelihood of significant results due to 
chance with multiple testing, we only analyzed significance for baseline variables that appeared to have 
large between-race differences and held potential value in comparison. We used odds ratios (OR) with 
95% confidence intervals (95% CI) and performed chi-square tests to assess the statistical significance of 
between-race differences in quality measure adherence, percentage that completed an advance directive, 
percentage referred to hospice, and percentage with a change in treatment plan. Clinical encounters for 
white patients served as the referent group because they were more frequent than encounters for black 
patients. All differences with p-values less than 0.05 were considered significant. All analyses were 
performed using STATA 14 (StataCorp, College Station, TX). 
 
RESULTS 
Baseline Patient and Encounter Characteristics 
 Between July 1, 2014 and June 30, 2015, there were 603 unique patients seen by the inpatient 
specialty palliative care service, accounting for a total of 664 clinical encounters (Table 2). Fifty patients 
had more than one encounter during the study period, but only six patients had more than two 
encounters. White patients comprised 397 (59.8%) of the 664 total encounters and 365 (60.3%) of the 
603 unique patients. There were 208 encounters for black patients (31.3%) and 186 unique black patients 
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(30.8%). The non-black and non-white patient population consisted of three Asian patients, three 
American Indian/Alaska Native patients, 15 patients of Other Race, and 31 patients with no race 
recorded. These patients were excluded from analyses, as we compared only black and white patients.  
 With respect to ethnicity, there were 28 clinical encounters (4.2%) for Hispanic/Latino patients. 
Only two clinical encounters were for white patients who were Hispanic/Latino; the remaining white 
patient encounters (99.5%) and all black patient encounters were Not Hispanic/Latino. The clinical 
encounters for the two white, Hispanic/Latino were included in the category of white patient encounters 
for data analysis; clinical encounters for the remaining 26 Hispanic/Latino patients were excluded. 
 Clinical encounters for black patients closely resembled encounters for white patients with 
respect to gender balance, prevalence of prior 30-day hospital readmissions, time between admission and 
palliative care consultation, distribution of PPS scores, and patient-reported moderate or severe pain 
(Table 2). In comparison to white patients, black patients were slightly younger, less likely to be married, 
and less likely to have dementia. Clinical encounters for black patients were also associated with longer 
hospital stays with a mean increase of nine days compared to hospital stays for white patient encounters 
(Table 2). The most common three diagnostic categories were identical for black and white patient 
encounters: cancer, cardiovascular, and neurologic conditions (Table 2). 
 The largest differences in characteristics between black and white patient encounters were 
related to treatment preferences. Compared to white patient encounters, black patient encounters were 
significantly more likely to have patients starting with Full Code status (73.6% versus 52.6%; p<0.0001) 
and more likely to have a primarily disease-directed treatment plan at the beginning of palliative care 
consultation (67.3% versus 46.9%; p<0.001). Additionally, black patient encounters were less likely than 
white patient encounters to include report of a prior advance directive (24.5% versus 34.3%; p=0.0138) 
(Table 2).  
Quality Measure Adherence and Clinical Encounter Outcomes  
 Among both black and white patient encounters, adherence was highest for the Treatment 
Preferences, Bowel Regimen with Opioid, and Pain Screening measures and lowest for the Pain 
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Assessment and Spiritual/Religious Concerns measures. The Dyspnea Treatment measure had the lowest 
adherence for both black and white patient encounters. Rates of adherence to palliative care quality 
measures ranged from 40.3% and 43.3% for Pain Assessment to 97.6% and 97.2% for Treatment 
Preferences in black and white patient encounters, respectively (Table 3).  
 Overall, adherence to quality measures was statistically similar between black and white patient 
encounters except for a small but significant difference in adherence to the Spiritual/Religious Concerns 
measure (Table 3). Clinical encounters for black patients were 1.45 times as likely to meet the 
Spiritual/Religious Concerns measure than white patient encounters (95% CI: 0.99 to 2.11, p=0.044). 
Clinical encounters for black and white patients performed similarly on the composite measure of quality 
of palliative care (83.5% and 82.2% adherence, respectively).  
 With respect to other clinical encounter outcomes during hospitalization, hospice referrals were 
significantly less common in black patient encounters than in white patient encounters (OR 0.75, 95% 
CI: 0.56 to 0.99; p=0.041). However, there were no significant differences between black and white 
patient encounters in advance directive completion, changes in treatment plan to a less aggressive plan, 
or new DNR orders (Table 3). 
 
DISCUSSION 
 Our study demonstrates that during the one-year study period, an inpatient specialty palliative 
care consultation service provided care of equal quality to patients irrespective of white versus black 
race.  In this study, quality of palliative care was defined by meeting multiple NQF-endorsed quality 
measures in clinical encounters. Between-race differences in quality measure adherence were significant 
only for Spiritual/Religious Concerns with black patient encounters more likely to include discussion of 
spiritual and religious concerns than white patient encounters (Table 3). In contrast, in the hospice 
setting, based on AHRQ analyses of HIS data, there is evidence of small but statistically significant 
disparities in adherence to the Pain Screening, Pain Assessment, Dyspnea Screening, Dyspnea 
Treatment, and Spiritual/Religious Concerns measures, with white race and non-Hispanic ethnicity 
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generally associated with higher quality measure adherence.
28
 The large sample size in this data set 
(3,922 hospice organizations and approximately 1.2 million patient stays) increases the power to detect 
small differences in measure adherence between racial and ethnic subgroups, which may or may not be 
clinically meaningful. 
 In this single-site specialty palliative care service, spiritual/religious concerns were more often 
addressed in encounters with black patients (70.2%) than with white patients (62.0%), yet the opposite 
pattern was observed in national data for hospice care. Discussions of spiritual and religious concerns 
were statistically less likely to occur for black non-Hispanic hospice patients (90.6%) than for white non-
Hispanic hospice patients (94.2%).
27
 Current data cannot differentiate clinician versus patient initiation 
of attention to spiritual needs, but awareness of this difference may help address this care disparity in 
both hospice and inpatient specialty palliative care. 
 Another interesting finding was the equal attention to pain screening and pain assessment 
regardless of patient race, which counters the literature on racial disparities in pain care and 
experience.
9,11,29
 Descriptive research across multiple care settings and pain types, including acute, 
chronic non-cancer, and cancer pain, has found that black and Hispanic/Latino patients receive less 
adequate pain assessment, less effective pain management, and reduced opioid analgesia relative to non-
Hispanic white patients.
9,11
 One retrospective study of 980 cancer patients seen at an outpatient palliative 
care center found that, compared to non-Hispanic white patients, Hispanic and non-Hispanic black 
patients were more likely to report severe pain upon initial presentation and less likely to report 
significant improvement in pain or fatigue at follow-up.
30
 In contrast, another retrospective study of 217 
hospitalized veterans found no differences in pain assessment or pain treatment plan documentation 
between black, Hispanic, and non-Hispanic white patients admitted to general medicine wards or the 
medical intensive care unit.
31 
Proposed contributors to pain management disparities include patient-
related factors, such as differences in pain sensitivity, preferred coping strategies, and attitudes about 
pain and pain treatment; provider-related factors, such as implicit bias and inadequate training in pain 
assessment; and factors related to the health care system, such as minorities’ decreased access to care, 
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lack of insurance coverage, and limited opioid availability in local pharmacies.
11
 However, none of the 
prior studies examined pain management by specialty palliative care teams, which may differ due to their 
expertise in pain control in patients with serious illnesses. 
 Our findings of similar pain screening and assessment rates in black and white patient encounters 
may illustrate the potential for inpatient specialty palliative care consultation to reduce pain assessment 
disparities between seriously ill black and white patients. Pain is an essential component of symptom 
assessment in palliative care, so palliative care specialists may be more likely than general medicine 
practitioners or oncologists to screen for and assess pain. Further, their specialty training may alleviate 
the effects of implicit bias that contributes to pain assessment disparities by other clinicians. The 
particular context of an inpatient setting and specialty consultation service may also level the playing 
field between black and white patients, removing health care system-related variables that grant greater 
privilege to white patients in accessing health care services, including pain management and oncology 
care, and obtaining opioid medications in community settings. 
 Our findings are consistent with previous studies documenting greater preference for and use of 
life-sustaining treatments, as well as lower rates of advance directive completion, in black patients 
compared to white patients.
14,32
 At baseline, encounters for black patients were significantly more likely 
to have patients with Full Code status, a primarily disease-directed treatment plan, and no prior advance 
directive than encounters for white patients (Table 2). Thus, it is unsurprising that hospice referrals were 
significantly less common in black patient encounters than in white patient encounters (OR 0.67, 95% 
CI: 0.46 to 1.00; p=0.041). The different patterns of care preferences, treatment use, and advance care 
planning in black versus white patients have been attributed to a variety of factors, including different 
spiritual and cultural values;
14,33
 gaps in knowledge about palliative care and advance directives;
33,34
 
socioeconomic barriers to hospice and palliative care access;
35
 and mistrust of the health care system 
among black Americans, in part due to past exploitation in research and ongoing structural racism.
36
 Our 
study was not designed to identify reasons behind between-race differences in code status, treatment 
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plans, prior advance directives, and hospice referrals, but it is important for palliative care clinicians to 
be aware of these long-standing population differences and their potential underlying explanations. 
 Of note, although the prevalence of prior advance directives was about 10% lower in black 
patient encounters than in white patient encounters, rates of new advance directive completion and new 
DNR orders after palliative care consultation were statistically similar in black and white patient 
encounters (Table 3). Inpatient specialty palliative care consultation is not the ideal context for advance 
care planning as many patients are incapable of decision-making in these encounters, likely explaining 
the low incidence of advance directive completion overall. However, our findings of essentially equal 
rates of advance direction completion and new DNR orders between black and white patient encounters 
suggest that specialty palliative care consultation may be one opportunity to reduce the racial disparity in 
advance care planning.  
Limitations 
 Our study has several important limitations in its scope and methods. First, since this was a 
retrospective study based on medical record data, we were only able to assess documented care 
processes. Symptom assessments or discussions that were not documented would not count toward 
quality measures. Another limitation in using chart abstractions is lack of consistent documentation of 
ongoing treatments. However, quality monitoring is commonly conducted through medical record 
reviews, so adherence rates based on current documentation are likely valid estimates in comparison to 
other quality performance analyses. Our study demonstrates some difficulties in using QDACT-PC to 
retrospectively collect data from acute care hospitalizations and to calculate quality measures using 
specifications originally designed for hospice settings. These difficulties are important to take into 
consideration when implementing future quality reporting programs in palliative care settings outside 
hospice. 
 Second, our study was designed to evaluate quality based on process measures rather than 
outcome or patient experience measures. The NQF endorsed these measures after evaluating their 
underlying rationale and evidence, signaling their importance in palliative care practice and the 
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opportunity to improve in these areas.
27
 There is moderate to strong evidence supporting treatment of 
cancer pain, treatment of dyspnea in chronic lung disease, and advance care planning as interventions 
that support quality of life in palliative and end-of-life care,
37
 and there is good reason to assume that 
adequate pain and dyspnea assessment leads to appropriate treatment. Additionally, discussions of 
treatment preferences and spiritual concerns have the potential to improve patients’ understanding of 
illness and prognosis, satisfaction with patient-provider communication, and receipt of care consistent 
with their values and preferences. Currently, the Hospice CAHPS Survey is the primary tool used to 
measure patient and family experiences in hospice. To more candidly assess quality of palliative care in 
non-hospice palliative care settings, we need to develop valid, feasible quality measures of outcomes 
such as symptom control, satisfaction with care, quality of life, and caregiver distress. 
 Finally, we limited our comparisons to quality measure adherence and consultation outcomes 
between encounters for black versus white patients, largely due to the small sample size of other racial 
and ethnic groups. Studies on disparities in palliative and end-of-life care have focused primarily on 
black and Hispanic/Latino individuals in comparison to white patients, while research on disparities 
affecting other minorities is lacking. Multi-center studies in diverse settings would help increase the 
sample size of Asian, Native American, and other minority populations and elucidate disparities in 
palliative care access, quality, and outcomes in these groups.  
 
CONCLUSIONS 
  In a single-site inpatient specialty palliative care consultation service, black patients and white 
patients received equal quality of care based on adherence to seven NQF palliative care quality measures. 
Compared to white patients, black patients were more likely to have Full Code status and a primarily 
disease-directed treatment plan consultation before consultation and were less likely to be referred to 
hospice after consultation. However, rates of new advance directive completion and change in treatment 
plan toward more comfort-oriented goals were similar between the two patient groups. Our study fills a 
gap in the literature on racial/ethnic disparities in specialty palliative care, and more research is needed to 
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clarify whether inpatient palliative care consultation can offer an opportunity to reduce racial disparities 
in pain management, communication about treatment preferences, and quality of life in serious illness 
and the end of life. 
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Table 1. Selected quality measures and clinical encounter outcomes with associated specifications.
a 
Quality Measure Specifications 
1634: Pain Screening Numerator: Encounters in which patient rated pain on 0-10 scale, “Patient unable to 
respond,” or “Other: [write in]” for Pain Screening 
Denominator: All encounters 
1637: Pain 
Assessment 
Numerator: Encounters in which patient rated pain as 4 or higher AND at least 5 
elements of the 7-item comprehensive pain assessment were completed 
Denominator: All encounters in which patient rated pain as 4 or higher 
1639: Dyspnea 
Screening (MWM 4) 
Numerator: Encounters in which patient rated dyspnea on 0-10 scale, “Patient 
unable to respond,” or “Other: [write in]” for Dyspnea Screening 
Denominator: All encounters 
1638: Dyspnea 
Treatment (MWM 4) 
Numerator: Encounters in which patient rated dyspnea as 4 or higher AND 
appropriate treatment for dyspnea was provided 
Denominator: All encounters in which patient rated dyspnea as 4 or higher 
1617: Bowel Regimen 
with Opioid 
Numerator: Encounters in which patient was prescribed long-acting or scheduled 
short-acting opioids AND bowel regimen was prescribed OR there is 
documentation of a valid contraindication to prescribing bowel regimen 
Denominator: All encounters in which patient was prescribed long-acting or 
scheduled short-acting opioids 
1641: Treatment 
Preferences  
(MWM 8) 
Numerator: Encounters in which a new MOST form, living will, GOC discussion, 
ACP note, and/or “Other: [write-in]” was completed after the initial encounter visit 
but before hospital discharge 
Denominator: All encounters 
1647: Spiritual and 
Religious Concerns 
(MWM 6)
 
Numerator: Encounters in which the patient or patient’s family was asked about 
spiritual or religious concerns within 5 days of the initial encounter visit 
Denominator: All encounters 
Composite Measure
 
Numerator: Encounters with screening for pain and dyspnea; pain assessment if 
pain level ≥4; dyspnea treatment if dyspnea level ≥4; bowel regimen if opioid use 
present; treatment preferences discussed via new MOST form, living will, GOC 
discussion, ACP note, or “Other: [write-in]” completed; and spiritual/religious 
concerns addressed. 
Denominator: All encounters 
Consultation 
Outcome 
Specifications 
Advance directive 
completion 
Numerator: Encounters in which the patient completed an advanced directive the 
initial encounter visit but before hospital discharge 
Denominator: All encounters 
Hospice referrals Numerator: Encounters in which the patient was referred to hospice after the initial 
encounter visit but before hospital discharge 
Denominator: All encounters 
Change in treatment 
plan 
Numerator: Encounters in which the patient’s treatment plan changed after the 
initial encounter visit but before hospital discharge 
Denominator: All encounters 
a. Except for measure #1641: Treatment preferences, all quality measures were calculated based on data from the 
initial consultation visit in the QDACT-PC database. The consultation service database served as the data source 
for the Treatment preferences measure, advance directive completion, hospice referrals, and change in treatment 
plan. Measures included in Measuring What Matters are also indicated. Acronyms: MWM, Measuring What 
Matters; MOST, Medical Orders for Life-Sustaining Treatment; GOC, Goals of Care; ACP, Advance care 
planning. 
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Table 2. Characteristics of clinical encounters for black versus white patients seen on the inpatient 
specialty palliative care consultation service between July 1, 2014 and June 30, 2015.
a 
 
Patient and Encounter 
Characteristics 
Black patient encounters 
N=208 
White patient encounters  
N=397 
Mean age (range) 58.7 (22.7 to 90.9) 64.9 (22.8 to 96.3) 
Female gender (%) 113 (54.3) 227 (57.2) 
Marital status (% married) 74 (35.6) 190 (47.9) 
Most common 3 diagnostic 
categories (% for each)
 
Cancer: 93 (44.7) 
Cardiovascular: 56 (26.9) 
Neurologic: 20 (9.6) 
Cancer: 196 (49.4) 
Cardiovascular: 60 (15.1) 
Neurologic: 35 (8.8) 
 
30-day hospital readmission (%)
b 
76 (36.5) 142 (35.8) 
Mean days of hospital stay 
(range) 
27.2 (2 to 455) 18.2 (0 to 419) 
Mean days between admission 
and consultation (range) 
10.4 (0 to 118) 8.8 (0 to 115) 
Presence of dementia (%) 7 (3.4) 31 (7.8) 
Functional status: PPS 
     0-30 (%) 
     40-60 (%) 
     70-100 (%) 
     Unknown 
 
72 (34.6) 
109 (52.4) 
11 (5.3) 
16 (7.8) 
 
142 (35.8) 
216 (54.4) 
28 (7.1) 
11 (2.8) 
Pain level 
     None or mild: 0-3 (%) 
     Moderate: 4-6 (%)
 
     Severe: 7-10 (%) 
     Unable to respond 
     Unknown 
 
109 (52.4) 
36 (17.3) 
34 (16.4) 
15 (7.2) 
13 (6.3) 
 
187 (47.1) 
68 (17.1) 
66 (16.6) 
44 (11.1) 
28 (7.1) 
Resuscitation preference 
     Full code 
     DNR/DNI 
     Code with Limitations 
     Unknown 
 
153 (73.6)
* 
41 (19.7) 
13 (6.3) 
1 (0.5) 
 
209 (52.6) 
166 (41.8) 
18 (4.5) 
3 (0.8) 
Has advance directive 51 (24.5)
 
136 (34.3) 
Treatment Plan 
      Primarily disease-directed 
      Mixture 
      Primarily palliative  
 
140 (67.3)
* 
59 (28.4) 
9 (4.3) 
 
186 (46.9) 
171 (43.1) 
40 (10.1) 
a
 Date obtained from initial palliative care visit for each clinical encounter. 
b 
30-day hospital readmissions: patient had at least one acute inpatient hospital admission within 30 days prior to 
current admission. 
*Significant with p<0.0001 by chi-square test  
 Significant with p=0.0138 by chi-square test 
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Table 3. Quality measure adherence and outcomes in inpatient palliative care consultation 
encounters for black versus white patients. 
Abbreviations: DNR, Do Not Resuscitate. 
 
 
 
 
 
 
 
 
Quality measure  Numerator/ 
Denominator 
among black 
patients 
Measure 
adherence in 
black patients 
(%) 
Numerator/ 
Denominator 
among white 
patients 
Measure 
adherence in 
white patients (%) 
Odds ratio  
(95% CI) 
p-value 
Pain Screening 195/208 93.8 369/397 92.9 1.14 (0.56-2.45) 0.709 
Pain Assessment 27/67 40.3 58/134 43.3 0.88 (0.47-1.67) 0.686 
Dyspnea 
Screening 
176/208 84.6 335/397 84.4 1.02 (0.63-1.68) 0.940 
Dyspnea 
Treatment 
20/28 71.4 64/79 81.0 0.59 (0.20-1.85) 0.289 
Bowel Regimen 
with Opioid 
65/69 94.2 154/160 96.3 0.63 (0.14-3.16) 0.487 
Treatment 
Preferences 
203/208 97.6 386/397 97.2 1.16 (0.36-4.31) 0.789 
Spiritual/ 
Religious 
Concerns 
146/208 70.2 246/397 62.0 1.45 (0.99-2.11) 0.044 
Composite 
Measure 
832/996 83.5 1612/1961 82.2 1.10 (0.89-1.36) 0.366 
 
Encounter 
outcome 
Numerator/ 
Denominator 
among black 
patients 
Incidence in 
black patients 
(%) 
Numerator/ 
Denominator 
among white 
patients 
Incidence in white 
patients (%) 
Odds ratio  
(95% CI) 
p-value 
New advance 
directive 
17/208 8.2 32/397 8.1 1.01 (0.58-1.78) 0.962 
Referral to 
hospice 
49/208 23.6 125/397 31.5 0.75 (0.56-0.99) 0.041 
Change in 
treatment plan to 
less aggressive 
plan 
90/208 43.3 192/397 48.4 0.89 (0.74-1.08) 0.234 
New DNR order 53/208 25.5 86/397 21.7 1.18 (0.87-1.59) 0.289 
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